Synapse
⌘+K
Sign In
Sign Up for Free
Synapse
Sign In
Sign Up for Free
Home
Communities
Explore
More
Language
English
English
Roche (Italy)
h-index: 78
Total citations: 28,484
Total papers: 566
Homepage:
https://www.roche.com/
Recent papers from Roche (Italy)
Subcutaneous Ocrelizumab for the Treatment of Relapsing Forms of Multiple Sclerosis: A Budget Impact Model
PharmacoEconomics - Open · 2026
Italian Delphi Consensus on Maternity Care in Multiple Sclerosis: Toward an Interdisciplinary Model of Care
European Journal of Neurology · 2026
Impact of Ministerial Decree 77/2022 from different stakeholders’ perspectives: clinicians, pharmacists, patients, and industry
Global & Regional Health Technology Assessment · 2026
Ocrelizumab in early relapsing–remitting multiple sclerosis: first interim analysis of the MUSPO Italian prospective cohort
Journal of Neurology · 2026
Dual valorization of sewage sludge ash through phosphorus recovery and wastewater remediation
Journal of Environmental Management · 2026
Identification of Predictive Genomic Biomarkers in Metastatic Clear Cell Renal Cell Carcinoma: A Comprehensive Analysis of Real-World Clinicogenomic Data
JCO Precision Oncology · 2026
Polatuzumab Vedotin and Glofitamab for Relapsed/Refractory Diffuse Large B‐Cell Lymphoma in the Compassionate Use Program in Italy
Hematological Oncology · 2025
Notulae to the Italian alien vascular flora: 20
Italian Botanist · 2025
Genomic profiling in hepatocellular carcinoma: a real-world retrospective analysis
ESMO Open · 2025
Prognostic and predictive implications of tumor suppressor gene alterations in non-small cell lung cancer
Scientific Reports · 2025
Leveraging Real-World Data From a Clinicogenomic Database Addresses the Treatment Gap in Patients With High-Grade Serous Ovarian Cancer.
2025
Cost-Estimation Model of Prevented Recurrences with Atezolizumab in Early Non-Small-Cell Lung Cancer in Italy
Clinical Drug Investigation · 2025
Faricimab in the Treatment of Exudative Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema in Italy: The FARIT Real World Study
Ophthalmology and Therapy · 2025
Impact of comprehensive genomic profiling and molecular tumour board on costs and access to tailored therapies: real-world observational study
BMJ Open · 2025
Proximity care pathways and digitalization: opportunities and concerns for medication safety management—Insights from the ProSafe study on community perspectives
Frontiers in Public Health · 2025
The genomic landscape of metastatic clear-cell renal cell carcinoma and its prognostic value: a comprehensive analysis of a large real-world clinico-genomic database
ESMO Open · 2025
Real-world evidence of anti-VEGF therapies in patients with neovascular age-related macular degeneration in Italy: The RADIANCE study
European Journal of Ophthalmology · 2025
Artificial intelligence-based pharmacological approach in non-small cell lung cancer in the precision medicine era
Cancer Treatment and Research Communications · 2025
Faricimab versus the standard of care for neovascular age-related macular degeneration in Italy: an indirect treatment comparison
Drug Target Insights · 2024
A 1-year per-patient cost of therapy administration analysis of mosunetuzumab and tisagenlecleucel in relapsed or refractory follicular lymphoma patients receiving two or more lines of systemic therapy
Global & Regional Health Technology Assessment · 2024